June 23-27, 2024 Barcelona
![]() |
![]() |
![]() |
![]() |
P-002 | Optimising Occupational Safety in Blood Services: The successful Australian experience of decreasing biological exposures and improving hepatitis B vaccination | Veronica Hoad | ![]() |
![]() |
|||
P-023 | New Roster Planning Tool in Enhancing Efficiency for Roster Planning at Blood Collection Sites | Javier Wong | ![]() |
![]() |
|||
P-24 | Do operators in the processing lab recognize the value of IT connectivity? | Marcia da Silva Cardoso | ![]() |
![]() |
|||
P-26 | Development of a National Dashboard and Evidencing Effective Anaemia Management on Patient Outcomes The Journey so Far | Krystle Towell | ![]() |
![]() |
|||
P-037 | The Value of Digital Programming in Transfusion Medicine Continuing Education | Tony Casina | ![]() |
![]() |
|||
P-041 | Building a Culture of Voluntary Blood Donation in Latin America: The LUDS Initiative | Silvina Kuperman | ![]() |
![]() |
|||
P-047 | Laboratory aspects of transfusion training for haematology postgraduate doctors in training (PGDiTs): results of a UK-wide survey | Lorna Cain | ![]() |
![]() |
|||
P-052 | Adverse Events in pediatric large volume leukapheresis for peripheral blood stem cells collection. Critical variables to take into account for a safe procedure in children. A single site experience | Monica Puppo | ![]() |
![]() |
|||
P-076 | The Lebanese Red Cross Blood Services Roadmap to AABB Quality Certification | Diane De Coning | ![]() |
![]() |
|||
P-084 | The AABB Quality Certificate Program for Blood Banks and Transfusion Services in Low or Middle Income Countries (LMICs) as their First Step on the Quality Journey | Diane De Coning | ![]() |
![]() |
|||
P-093 | Have consent practices for blood transfusion changed in the last 10 years? | Linley Bielby | ![]() |
![]() |
|||
P-103 | Managing Chagas Indeterminate Donors: Changes Needed for Reentry and Lookback? | Rebecca Townsend | ![]() |
![]() |
|||
P-104 | Implementation of sexual risk behaviour donor screening in Canada | Mindy Goldman | ![]() |
![]() |
|||
P-107 | Facilitating access to potential blood donor groups in southern Ghana, using blood group testing intervention to promote blood donation | Lucy Asamoah-Akuoko | ![]() |
![]() |
|||
P-108 | Knowledge and self-perceptions of blood donation eligibility in Australia, and impact on blood donation intention | Yasmin Mowat | ![]() |
![]() |
|||
P-116 | Community-based research and engagement: understanding barriers to donation for communities of African and South Asian ancestry | Jennie Haw | ![]() |
![]() |
|||
P-138 | Demographic change of blood donors in Montenegro | Nela Erakovic | ![]() |
![]() |
|||
P-145 | Hospital-Based Blood Donation Centers Response to National Blood Shortage Around COVID-19 Pandemic | Fatima Aldarweesh | ![]() |
![]() |
|||
P-151 | A NOVEL PREDICTIVE ALGORITHM FOR POST-DONATION PLATELET COUNT: A MODEL SOFTWARE USED AT THE POINT OF CARE | Silvana Munayco | ![]() |
![]() |
|||
P-158 | JAK2-V617F Mutation Among Blood Donors and Donors with Incidentally Found Polycythemia: A Systematic Review and Meta-analysis | Maha Badawi | ![]() |
![]() |
|||
P-160 | A study of iron status of premenopausal first-time female donor associated with subsequent hemoglobin deferral | KUAN-HSIAO Lin | ![]() |
![]() |
|||
P-161 | Evaluation of the impact of a donor management system on donor deferrals for low haemoglobin at the Southern Zonal Blood Centre, Ghana | Lucy Asamoah-Akuoko | ![]() |
![]() |
|||
P-164 | Donor awareness on taking iron supplementation after blood donation in Singapore | Kyi Kyi San | ![]() |
![]() |
|||
P-168 | Association of blood donation with the risk of cardiovascular disease in whole blood donors | Ling-I Hsu | ![]() |
![]() |
|||
P-169 | Are Canadian blood donors more likely to have COVID-19 vaccination than the general population? | Sheila OBrien | ![]() |
![]() |
|||
P-179 | Factors associated with systematic differences in capillary and venous hemoglobin measurement in a large diverse blood donor cohort | Bryan Spencer | ![]() |
![]() |
|||
P-180 | Impact of Bidirectional Data Interface on Operational Errors in Platelet Apheresis Collections: A Comparative Analysis Before and After Implementation | Marcia Cardoso | ![]() |
![]() |
|||
P-181 | Increased plasma volume collected on a plateletpheresis separator | Leticia Thys | ![]() |
![]() |
|||
P-183 | How to operate a sustainable plateletpheresis programme in LMIC: Experience from Namibia | Marcia Cardoso | ![]() |
![]() |
|||
P-185 | Evaluation of improved device software for the collection of apheresis platelets: reinfusion time and loss of red blood cells | Axel Stover | ![]() |
![]() |
|||
P-186 | Optimizing Blood Donation Workflow: A study on Integrating Donor Registration and Hemoglobin Testing for Improved Pre-donation Efficiency | Hong Wu | ![]() |
![]() |
|||
P-190 | IMPLEMENTATION OF DONOR THROMBOCYTOPHERESIS IN THE INSTITUTE FOR BLOOD TRANSFUSION IN MONTENEGRO | Marina Sekulic | ![]() |
![]() |
|||
P-192 | Incidence of adverse events during platelet apheresis collections in single and double collections. | Marcia da Silva Cardoso | ![]() |
![]() |
|||
P-194 | Using Estimated Blood Volume (EBV) to predict the risk of vasovagal reactions in whole blood donors in Singapore | Sheryl Therese Go Ang | ![]() |
![]() |
|||
P-209 | Maintaining the sterility of welded tubing using MacoSeal LIGHT | sylvie lefebvre | ![]() |
![]() |
|||
P-214 | A multicentre European validation study of hypoxic red blood cells | James Nada Hourani | ![]() |
![]() |
|||
P-215 | A novel viscoelastic testing platform for the assessment of haemostatic function in stored platelets | Lacey Johnson | ![]() |
![]() |
|||
P-223 | Performance Validation of TERUMOBCT REVEOS Automated Blood Processing System in Blood Service of Singapore | Cai Yun Goh | ![]() |
![]() |
|||
P-231 | A comparison of manual vs. automated hematocrit measurement in red blood cell concentrates in PAGGSM additive solution | Geraldine Walsh | ![]() |
![]() |
|||
P-233 | Development and validation of transport boxes validation for red blood cell concentrates by unmanned automated drone | anais lotens | ![]() |
![]() |
|||
P-243 | Platelet Production: Reducing Risk in Assembling Platelet Pools from Buffy Coat with the support of software | Sabrina Battista | ![]() |
![]() |
|||
P-250 | Long-COVID patients show enhanced formation of COHb and accumulation of toxic porphyrin intermediates in erythrocytes | Romy Kronstein-Wiedemann | ![]() |
![]() |
|||
P-252 | Evaluating batch variation in human platelet precipitate and human platelet lysate | Lacey Johnson | ![]() |
![]() |
|||
P-254 | Impact of changing from PVC-DEHP to PVC-DEHT whole blood collection sets on plasma in vitro quality | Geraldine Walsh | ![]() |
![]() |
|||
P-258 | Oxygen saturation levels of red cell concentrates awaiting clinical issue, across 33 days of storage | Peter Smethurst | ![]() |
![]() |
|||
P-259 | Preliminary study evaluating spray dried UK plasma in a blood bag | Lucy Bower | ![]() |
![]() |
|||
P-260 | Rapid thawing of FFP with a 45C dry tempering cycle maintains critical coagulation parameters | Kazuhiko Ikeda | ![]() |
![]() |
|||
P-262 | Descriptive study of the use of cryopreserved platelet concentrates in the hospital setting | Pérez Aliaga Ana Isabel | ![]() |
![]() |
|||
P-263 | Leukoreduced blood components: the strategy for using a new method for blood quality control | Nadine Marpaux | ![]() |
![]() |
|||
P-268 | ANALYSIS OF THE ESTIMATED VOLUME OF THE PLATELET CONCENTRATES BY AN AUTOMATED SYSTEM | Marcia da Silva Cardoso | ![]() |
![]() |
|||
P-269 | OPTIMIZING RAPID PLASMA FREEZING TO ENHANCE EFFICIENCY IN PLASMA PRODUCTION FOR MEDICAL USE: A CASE STUDY IN THE REPUBLIC OF BELARUS | Ala Novik | ![]() |
![]() |
|||
P-276 | Routine use of digital microscope for residual white blood cells counting in a quality control lab | anais lotens | ![]() |
![]() |
|||
P-284 | Increased potassium release in X-ray irradiated deglycerolised red blood cells | Lacey Johnson | ![]() |
![]() |
|||
P-286 | Immunoglobulin therapy in Chronic Lymphocytic Leukemia: Data linkage study | Sara Carrillo De Albornoz | ![]() |
![]() |
|||
P-287 | Use of Intravenous Albumin: A Guideline from the International Collaboration for Transfusion Medicine Guidelines | Jeannie Callum | ![]() |
![]() |
|||
P-289 | Navigating the Healthcare Journey: Immune Globulin Recipients Experiences and Engagement in the Health System | Kelly Holloway | ![]() |
![]() |
|||
P-294 | Elevated plasma testosterone concentrations with males on testosterone replacement therapy are mitigated with pathogen reduction technology. | Waseem Anani | ![]() |
![]() |
|||
P-303 | Successful Inactivation of pathogenic bacterial strains in double-dose pooled buffy coat platelet using Amotosalen/UVA pathogen reduction treatment | Mark Lambert | ![]() |
![]() |
|||
P-310 | OPTIMIZATION AND IN-VITRO QUALIFICATION OF PATHOGEN REDUCED DOUBLE DOSE POOLED PLATELETS OF SEVEN BUFFY COATS THROUGHOUT 8 DAYS OF STORAGE | Alice Lorusso | ![]() |
![]() |
|||
P-316 | Dose-dependent inactivation of Plasmodium falciparum in red blood cell concentrates by treatment with short wavelength ultraviolet light | Ute Gravemann | ![]() |
![]() |
|||
P-321 | Quality comparison of red Blood Cell Concentrates between DEHT-PAGGSM bags and DEHT-SAGM bags 49 days storage study | anais lotens | ![]() |
![]() |
|||
P-323 | Restoration of actin network dynamics as a possible key to efficient in vitro production of erythrocytes | Romy Kronstein-Wiedemann | ![]() |
![]() |
|||
P-334 | Impact of different process preparations on the Red Cell Concentrate quality with a combination DEHT-PAGGSM multicentric study | anais lotens | ![]() |
![]() |
|||
P-335 | A Comparative Study on the Properties of Pig and Human Blood: Implications for Xenotransfusion Practice | Juhye Roh | ![]() |
![]() |
|||
P-336 | Understanding the potential benefits of Universal Platelets and Universal Plasma for the English blood service | Lorna Cain | ![]() |
![]() |
|||
P-340 | Understanding the potential benefits of Universal Platelets for hospitals in England | Lorna Cain | ![]() |
![]() |
|||
P-348 | Using sequential immunoassays for the screening of syphilis in blood donors | Anthea Cheng | ![]() |
![]() |
|||
P-350 | PRELIMINARY CLINICAL PERFORMANCE AND ANALYTICAL SENSITIVITY OF A NEW MULTIPLEX BLOOD SCREENING ASSAY FOR DETECTION OF MOSQUITO-BORNE VIRUSES ON A FULLY AUTOMATED SYSTEM | kristin livezey | ![]() |
![]() |
|||
P-353 | Biotin supplement intake and detection of high plasma levels in blood donors: assessing the risk of immunoassay interference | Adriana Urbina | ![]() |
![]() |
|||
P-356 | Cleaning effect with improvement of specificity between May 2022 and December 2023 after changing ID serology screening assays to another supplier at the Hungarian National Blood Transfusion Service | Walter Melchior | ![]() |
![]() |
|||
P-361 | Comparison of the specificity of a multiplex nucleic acid test for HIV, HCV, and HBV performed on two versions of an automated analyzer | Susan Galel | ![]() |
![]() |
|||
P-362 | PERFORMANCE EVALUATION STUDY OF ELECSYS IMMUNOASSAYS IN BLOOD DONORSCREENING IN SALTA, ARGENTINA | David Callejas | ![]() |
![]() |
|||
P-375 | Ten-year follow-up program for donors with occult hepatitis B virus infection in Dalian, China | Daniel Candotti | ![]() |
![]() |
|||
P-393 | RESULTS OF SCREENING ANTIBODIES TO THE NUCLEAR ANTIGEN ANTI-HB-CORE AMONG DONORS IN THE KARAGANDA REGION | Zhanar Ibrayeva | ![]() |
![]() |
|||
P-396 | Analysis of anti-HCV immunoassay sample to cutoff ratios in blood donors with positive results to aid recipient lookback risk assessments | Anthea Cheng | ![]() |
![]() |
|||
P-407 | Detection and molecular typing of Morganella morganii, a cause of transfusion-transmitted bacterial infections | Mami Matsumoto | ![]() |
![]() |
|||
P-408 | Environmental Bacterial Screening in the Blood Center | Bethany Brown | ![]() |
![]() |
|||
P-410 | Cutibacterium acnes does not enhance the release and accumulation of proinflammatory factors in platelet concentrates during storage | Sandra Ramirez-Arcos | ![]() |
![]() |
|||
P-415 | Sociodemographic factors associated with reactivity in syphilis serology among Brazilian blood donors from January 2020 to February 2022 | Vivian Avelino-Silva | ![]() |
![]() |
|||
P-418 | Impact of the introduction of specific treponemal antibody detection in syphilis screening in a center that had been using RPR for 30 years | María José Candela García | ![]() |
![]() |
|||
P-421 | Analytical sensitivity of a donor screening assay for Plasmodium ribosomal RNA and DNA | Susan Galel | ![]() |
![]() |
|||
P-422 | Laboratory detection of donors implicated in transfusion-transmitted malaria | Susan Galel | ![]() |
![]() |
|||
P-424 | Screening and testing of blood donors for Chagas disease based on recent travel destinations: Results from an international survey conducted by the ISBTs TTID working party | Lewin Antoine | ![]() |
![]() |
|||
P-425 | Transfusion-transmitted babesiosis due to travel escapes regional testing approach. | Laura Tonnetti | ![]() |
![]() |
|||
P-429 | PARVOVIRUS B19 SURVEILLANCE IN SWISS BLOOD DONORS: COMPARISON OF CURRENT AND PREVIOUS OUTBREAKS | MAURO SERRICCHIO | ![]() |
![]() |
|||
P-432 | Travel and sexual risk of Zika for cord blood donor: a risk-based approach | Lewin Antoine | ![]() |
![]() |
|||
P-438 | A negligible risk of transfusion-transmitted SARS-CoV-2 in populations with high immunization coverage during the first Omicron surge in Taiwan. | Yun-Yuan Chen | ![]() |
![]() |
|||
P-441 | Assessing the West Nile Virus transfusion-transmission risk in a Blood Bank located in a Mediterranean archipelago: a blood donor screening study | Gabriela Capllonch-Amer | ![]() |
![]() |
|||
P-442 | Asymptomatic West Nile Virus Prevalence Amongst Canadian Blood Donors Compared to Clinically Reported Cases Across Canada | Carmen Charlton | ![]() |
![]() |
|||
P-444 | Parvovirus B19 but not hepatitis A nucleic acid test positivity rates in Canadian plasma donors are still reduced in the pandemic recovery period | Steven Drews | ![]() |
![]() |
|||
P-450 | Immunodominance to Naturally Occurring RBC Alloantigens is Controlled by Non-Genetic Factors in Mice | James Zimring | ![]() |
![]() |
|||
P-461 | Provision of Mia-negative Red Cells for Transfusion in Patients with Anti-Mia in Conjunction with Multiple Antibodies | Zeng Hui | ![]() |
![]() |
|||
P-462 | Detecting the DVI Variant in the Obstetrical and Patient Populations | Tony Casina | ![]() |
![]() |
|||
P-470 | Stepping Up to serologic problem solving with anti-CD38 therapies | Jennifer Duncan | ![]() |
![]() |
|||
P-473 | Comparison of conventional tube technique with automated gel microcolumn assay for antenatal antibody monitoring | Kati Sulin | ![]() |
![]() |
|||
P-476 | Automated blood group antibody titrations using gel card column agglutination: equivalent accuracy for ABO and non-ABO antibody titres between automated and manual testing | Laziza Amniai | ![]() |
![]() |
|||
P-489 | Enhanced automated blood group antibody titration techniques: an exploration of the advantages | Laziza Amniai | ![]() |
![]() |
|||
P-499 | The Frequency of ABO, Rh, Kell and Duffy Blood Group Antigens in a Homogeneous Ethnic Nigerian Population | Oluwafemi Ajayi | ![]() |
![]() |
|||
P-501 | Clinical case of TN- polyagglutination in a patient with nasal bleeding | Elizaveta Kim | ![]() |
![]() |
|||
P-511 | Incidental Discovery of Anti-Wra in Two Cases with Coexisting Autoantibodies | Kai Ru Teoh | ![]() |
![]() |
|||
P-516 | Frequencies of blood group antigens and phenotypes in the Northern Vietnamese population | Tung Nguyen | ![]() |
![]() |
|||
P-524 | SEROLOGICAL EVALUATION OF INCOMPATIBLE CROSS MATCHES ENCOUNTERED IN PRE-TRANSFUSION TESTING | Anisha Badoni | ![]() |
![]() |
|||
P-537 | Blood provision for a patient with Anti-IH and subsequent laboratory improvements | Megan Gallagher | ![]() |
![]() |
|||
P-549 | Feasibility study of the use of BLOODchipID genotyping assays with FLEXMAP 3D system | monica lopez | ![]() |
![]() |
|||
P-552 | Three new XK alleles accounting for the McLeod phenotype in the Kx blood group system | Toru Miyazaki | ![]() |
![]() |
|||
P-557 | CHARACTERIZATION OF A NOVEL RHCE*CeCW VARIANT ALLELE | Bernd Schimanski | ![]() |
![]() |
|||
P-561 | Genomic exome sequencing to resolve complex blood group problems | Genghis Lopez | ![]() |
![]() |
|||
P-562 | Mixed Erythrocyte Phenotypes: An Indirect Sign of Clonal Hematopoiesis? | Rhita Bennis | ![]() |
![]() |
|||
P-597 | The identification methods for antigen D | Elizaveta Kim | ![]() |
![]() |
|||
P-604 | Rare Donor Programs and IgA Deficiency Defining the Landscape | Douglas Roberts | ![]() |
![]() |
|||
P-608 | Managing a Frozen Rare Blood Inventory: A Survey of American Rare Donor Program Member Facilities | Margaret Keller | ![]() |
![]() |
|||
P-611 | CREATION OF A REGISTER OF CHILEAN BLOOD DONORS WITH RARE PHENOTYPES FROM THE SANTA MARIA CLINIC BLOOD BANK. | Maria Nuñez | ![]() |
![]() |
|||
P-616 | The Creation and Development of the Irish Rare Donor Programme | Moira Keogh | ![]() |
![]() |
|||
P-619 | Application of successful PBM measures to manage a patient with a rare anti-Cra antibody | Chloe George | ![]() |
![]() |
|||
P-631 | Selection of appropriate capture antibody and detergent is crucial for detection of anti-Nak(a) (anti-CD36) antibodies in immunocomplex capture fluorescence analysis (ICFA) | Hiromi Kamada | ![]() |
![]() |
|||
P-635 | Detect rare allele frequency of human platelet antigens in Taiwanese population through Taiwan Biobank Dataset | Lei-Fang Tsai | ![]() |
![]() |
|||
P-637 | Glycoprotein V is a new target for platelet autoantibodies in immune thrombocytopenia (ITP): the experience of the Platelet Immunology Reference Laboratory of Rennes (France) | Gerald Bertrand | ![]() |
![]() |
|||
P-644 | AUTOMATED METHOD FOR ANTI-BLOOD GROUP ANTIBODY TITRATION IN PLATELET CONCENTRATES | Pilar Solves Alcaina | ![]() |
![]() |
|||
P-661 | Non-invasive prenatal testing utilising massively parallel sequencing for blood group genotyping of alloimmunised pregnant women in a single test system | Mia Sarri | ![]() |
![]() |
|||
P-667 | CLINICAL MANAGEMENT OF ANTI-KELL ALLO-IMMUNIZATION IN PREGNANCY: A CASE REPORT | Gianluca Gessoni | ![]() |
![]() |
|||
P-679 | Does the current guidance for the use of prophylactic anti-D meet the requirement for pregnant women? | Andreia Peca | ![]() |
![]() |
|||
P-683 | Evaluation of the Causes of a Positive Direct Antiglobulin Test (DAT) in New-Borns | Samantha Reynolds | ![]() |
![]() |
|||
P-684 | Red cell alloimmunization in Intrauterine transfusion cases in the Royal Hospital (10 years experience) | Halima Al Bulushi | ![]() |
![]() |
|||
P-689 | Anti-K antibody, repeated intrauterine transfusions and further immunisation how to survive complications | Helena Hoffmanová | ![]() |
![]() |
|||
P-691 | Maternal-fetal conflict due to anti-Kell (K) and anti- Kidd (Jkb) antibodies detected during the second trimester of pregnancy, with fetal demise at 37 weeks of gestation | Eric Alarcón | ![]() |
![]() |
|||
P-713 | Efficacy of Therapeutic Apheresis Procedures in a Tertiary Hospital: Alignment with Scientific Guidelines | Enrique Blanco Peláez | ![]() |
![]() |
|||
P-727 | Plasma proteome profiling reveals signatures of Inflammation and Dysregulation of Hemostasis in Acute Myeloid Leukemia Patients undergoing Intensive-Transfusion Treatment | Diana Carolina Munoz Sandoval | ![]() |
![]() |
|||
P-733 | Audit of transfusion rates in Australian lung transplant patients | Ruby Garland | ![]() |
![]() |
|||
P-736 | Complexities of red blood cell (RBC) transfusion in patients with myelodysplastic syndromes (MDS): a prospective time-driven, activity-based study | Allison Mo | ![]() |
![]() |
|||
P-748 | Evaluation of the Provision of Crossmatch Compatible Platelets for Haematology Patients who have Acquired Non-Immune Refractoriness | Samantha Reynolds | ![]() |
![]() |
|||
P-752 | Impact of granulocyte transfusions in infected neutropenic bone marrow transplant patients | Ricardo Battaglini | ![]() |
![]() |
|||
P-773 | Adverse events during preoperative autologous blood donation and its usage in obstetrical patients: A multicenter, retrospective study in Japan | Akihiko Yokohama | ![]() |
![]() |
|||
P-774 | ABO incompatibility and component irradiation are independently associated with platelet transfusion reaction rate | Keenan Hogan | ![]() |
![]() |
|||
P-776 | PULMONARY COMPLICATIONS OF TRANSFUSION IN THE HAEMOVIGILANCE SYSTEM OF HOSPITAL INFANTA SOFÍA (MADRID) FROM 2019-2023 | Regina Herraez García | ![]() |
![]() |
|||
P-780 | IMMUNIZATION RATE IN RHD-NEGATIVE PATIENTS TRANSFUSED WITH RHD-POSITIVE RED CELL CONCENTRATES | Ana Pérez- Aliaga | ![]() |
![]() |
|||
P-781 | Basophil activation test using basophils from children with positive peanut- or buckwheat-specific immunoglobulin E and donor serum after ingesting the corresponding foods | Ryu Yanagisawa | ![]() |
![]() |
|||
P-783 | Transfusion reactions in IgA deficient patients: red flags or red herrings? | Elisabeth Davies | ![]() |
![]() |
|||
P-797 | ABO incompatibility Red Cell transfusions Review of Serious Hazards of Transfusion (SHOT) over the last 10 years | Florence Oyekan | ![]() |
![]() |
|||
P-799 | Blood Transfusion Safety in Patients Treated with Anti-CD38 Antibodies: Efficacy of a Pretransfusion Protocol Based on DaraEx in a Tertiary Hospital | Enrique Blanco Peláez | ![]() |
![]() |
|||
P-800 | Universal Prestorage Leukoreduction in RBC Transfusions Leads to Significant Reduction in Febrile Reactions Identified through Body Temperature Monitoring of Hospital Information System. | Yun-Yuan Chen | ![]() |
![]() |
|||
P-802 | Analysis of transfusion reactions reported to the Korean Haemovigilance System | Jungwon Hyun | ![]() |
![]() |
|||
P-805 | SAFETY BLOOD TRANSFUSION: ANALYSIS OF THE IMPACT OF THE HAEMOVIGILANCE NURSE IN THE HOSPITAL NETWORK OF THE COMMUNITY OF MADRID (SPAIN) | FÁTIMA HIPOLITO CASILLAS | ![]() |
![]() |
|||
P-806 | ADVANCING PATIENT CARE: COMPREHENSIVE REVIEW OF HOME BLOOD TRANSFUSIONS AT BURGOS UNIVERSITY HOSPITAL | Jhoana Delgado Torres | ![]() |
![]() |
|||
P-832 | Preoperative Anaemia Pathway: Ensuring Equitable Patient Management Across Wales | Krystle Towell | ![]() |
![]() |
|||
P-833 | How do I monitor quality indicators in transfusion medicine? A multicenter pilot study | García-Gala Jose María | ![]() |
![]() |
|||
P-836 | Knowledge and Practice among Clinicians Regarding Patient Blood Management Initiatives | Salwa Hindawi | ![]() |
![]() |
|||
P-837 | Management of anemia in patients with pre-end stage chronic kidney disease in a tertiary medical center in Taiwan | Wen-Jie Liu | ![]() |
![]() |
|||
P-868 | Evaluating the Effectiveness of Stem Cell Recruiting Policies Using a Dynamic Registry Simulation | JOHN BLAKE | ![]() |
![]() |
|||
P-887 | EXTRA CORPOREAL PHOTOPHERESIS IN TREATMEN OF GRAFT VERSUS HOST DISEASE USING A NEW ONLINE SYSTEM | Gianluca Gessoni | ![]() |
![]() |
|||
P-911 | Donor Increase without Specific HLA Antigens for Patients with Severe Platelet Immune Refractoriness after Rituximab Treatment. | Maria Nuñez | ![]() |
![]() |
June 23-27, 2024 Barcelona
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|